Natarajan Vijayasankaran
Advertisement
Natarajan Vijayasankaran is engineer II at late stage cell culture, US Biologics Pharma Technical Development, Genentech, Inc.
Articles by Natarajan Vijayasankaran
Advertisement
Latest Updated Articles
Systematic Approaches to Develop Chemically Defined Cell Culture Feed MediaPublished: November 1st 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
5
